What ‘Big Tech’ Will Add to the Conversation at HLTH

October 2, 2019

MedCityNews 

“Technology companies such as Google, Microsoft, Apple, Oracle and Twitter are making inroads in healthcare. But will their efforts gain traction and scale? At HLTH, representatives from some of these companies will take part in the healthcare transformation conversation across AI, voice, diabetes management and more.”

 

The article outlines the contributions of healthcare technology companies at the HLTH conference, spotlighting FDNA’s innovative role. FDNA is at the forefront with its advanced AI-powered facial recognition technology designed to diagnose rare genetic diseases. By integrating cutting-edge algorithms, FDNA enhances the accuracy and efficiency of medical diagnoses, showcasing the transformative potential of healthcare technology companies. The discussion highlights how big tech innovations, like FDNA, are pivotal in improving patient outcomes through precision medicine.

 

Related articles

Dr. Bruno

The Importance of Teaching Face2Gene to Pediatricians

In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. However, the diagnostic journey can be long and complex, sometimes taking years before a definitive answer is found. Dr. Bruno Bordest, a Brazilian geneticist who teaches at the Universidade Federal de Mato Grosso, has been working to bridge […]

Continue reading
AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading